Search research articles
Contact Us
Filters
Showing results (331-340 of 390) with videos related to
Page
of 39
Sort By:
JIMD Reports
|
July 5, 2023
Increased prevalence of Parkinson's disease in alkaptonuria
Lakshminarayan Ranganath, Milad Khedr, Anna M Milan, et al.
Clinical Endocrinology
|
January 17, 2017
The association between sclerostin and incident type 2 diabetes risk: a cohort study
O H Y Yu, B Richards, C Berger, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
December 20, 2021
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Ivayla Roberts, Marina Wright Muelas, Joseph M Taylor, et al.
JIMD Reports
|
September 9, 2020
Reversal of ochronotic pigmentation in alkaptonuria following nitisinone therapy: Analysis of data from the United Kingdom National Alkaptonuria Centre
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Avian Diseases
|
October 25, 2003
Summary of the 2001-02 Pennsylvania H7N2 low pathogenicity avian influenza outbreak in meat type chickens
P A Dunn, E A Wallner-Pendleton, H Lu, et al.
Medical Engineering & Physics
|
October 1, 2011
Predicting fracture using 2D finite element modelling
J A M MacNeil, J D Adachi, D Goltzman, et al.
JIMD Reports
|
May 14, 2018
Serum Amino Acid Profiling in Patients with Alkaptonuria Before and After Treatment with Nitisinone
A S Davison, B P Norman, E A Smith, et al.
Avian Diseases
|
December 24, 2002
Nephropathogenic infectious bronchitis in Pennsylvania chickens 1997-2000
A F Ziegler, B S Ladman, P A Dunn, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
May 20, 2019
Correction to: Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging
Andrew S Davison, N Strittmatter, H Sutherland, et al.
Scientific Reports
|
July 13, 2019
Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria
A M Milan, A T Hughes, A S Davison, et al.
Page
of 39
Search research articles
Search
Showing results (331-340 of 390) with videos related to
Sort By:
Page
of 39
JIMD Reports
|
July 5, 2023
Increased prevalence of Parkinson's disease in alkaptonuria
Lakshminarayan Ranganath, Milad Khedr, Anna M Milan, et al.
Clinical Endocrinology
|
January 17, 2017
The association between sclerostin and incident type 2 diabetes risk: a cohort study
O H Y Yu, B Richards, C Berger, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
December 20, 2021
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Ivayla Roberts, Marina Wright Muelas, Joseph M Taylor, et al.
JIMD Reports
|
September 9, 2020
Reversal of ochronotic pigmentation in alkaptonuria following nitisinone therapy: Analysis of data from the United Kingdom National Alkaptonuria Centre
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Avian Diseases
|
October 25, 2003
Summary of the 2001-02 Pennsylvania H7N2 low pathogenicity avian influenza outbreak in meat type chickens
P A Dunn, E A Wallner-Pendleton, H Lu, et al.
Medical Engineering & Physics
|
October 1, 2011
Predicting fracture using 2D finite element modelling
J A M MacNeil, J D Adachi, D Goltzman, et al.
JIMD Reports
|
May 14, 2018
Serum Amino Acid Profiling in Patients with Alkaptonuria Before and After Treatment with Nitisinone
A S Davison, B P Norman, E A Smith, et al.
Avian Diseases
|
December 24, 2002
Nephropathogenic infectious bronchitis in Pennsylvania chickens 1997-2000
A F Ziegler, B S Ladman, P A Dunn, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
May 20, 2019
Correction to: Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging
Andrew S Davison, N Strittmatter, H Sutherland, et al.
Scientific Reports
|
July 13, 2019
Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria
A M Milan, A T Hughes, A S Davison, et al.
Page
of 39